Figure 1From: CaMKII inhibition with KN93 attenuates endothelin and serotonin receptor-mediated vasoconstriction and prevents subarachnoid hemorrhage-induced deficits in sensorimotor function Experimental design. *Animals terminated at 1 h for evaluation of phosphorylated CaMKII with Western blot were treated with KN93 or placebo 45 min prior to and immediately after SAH.Back to article page